The mitral valve is an integral component of the cardiovascular system, situated within the heart to regulate blood flow. Nestled between the left atrium and left ventricle, this valve, characterized by its bicuspid structure, orchestrates the rhythmic passage of oxygenated blood during the cardiac cycle. Its two leaflets collaborate in a harmonious dance, opening and closing precisely to facilitate the unidirectional movement of blood. Ensuring the seamless flow of blood is vital for the heart's overall efficiency, and any deviation from normal mitral valve function can have profound implications. Conditions like mitral valve prolapse or stenosis, which affect the proper operation of this valve, may compromise the cardiovascular system's performance. Monitoring the health of the mitral valve is a critical aspect of comprehensive cardiovascular assessments conducted by healthcare professionals. In cases where issues with the mitral valve arise, the spectrum of treatment options varies. Healthcare providers may employ a range of interventions, from medications designed to regulate blood flow and alleviate symptoms to surgical procedures aimed at restoring optimal valve function. The choice of treatment depends on the specific nature and severity of the mitral valve condition.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt